Abbas Ardehali
#53,315
Most Influential Person Now
Iranian-American cardiothoracic surgeon
Abbas Ardehali's AcademicInfluence.com Rankings
Abbas Ardehalimedical Degrees
Medical
#559
World Rank
#757
Historical Rank
Surgery
#69
World Rank
#101
Historical Rank
Abbas Ardehaliphilosophy Degrees
Philosophy
#11024
World Rank
#15141
Historical Rank
Logic
#8019
World Rank
#9980
Historical Rank
Download Badge
Medical Philosophy
Abbas Ardehali's Degrees
- Doctorate Medicine Tehran University of Medical Sciences
Why Is Abbas Ardehali Influential?
(Suggest an Edit or Addition)According to Wikipedia, Abbas Ardehali is an Iranian-American cardiothoracic surgeon. He is the surgical director of UCLA's Heart, Lung, and Heart-Lung Transplant programs, and was the principal investigator behind technology that allows for the transportation of a breathing human heart or lung for an extended period of time.
Abbas Ardehali's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Atrial Extracellular Matrix Remodeling and the Maintenance of Atrial Fibrillation (2004) (366)
- Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial (2015) (331)
- Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. (2009) (195)
- High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. (2007) (184)
- Aspergillus Colonization of the Lung Allograft Is a Risk Factor for Bronchiolitis Obliterans Syndrome (2009) (174)
- Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation. (2015) (156)
- Role of CXCL9/CXCR3 Chemokine Biology during Pathogenesis of Acute Lung Allograft Rejection 1 (2003) (133)
- INHALED NITRIC OXIDE FOR PULMONARY HYPERTENSION AFTER HEART TRANSPLANTATION (2001) (132)
- Chemokine Monokine Induced by IFN-γ/CXC Chemokine Ligand 9 Stimulates T Lymphocyte Proliferation and Effector Cytokine Production1 (2004) (131)
- A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. (2009) (130)
- Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome. (2005) (126)
- Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study. (2018) (125)
- Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment. (2005) (122)
- Normothermic donor heart perfusion: current clinical experience and the future (2015) (119)
- HLA and MICA: Targets of Antibody-Mediated Rejection in Heart Transplantation (2011) (106)
- A PROSPECTIVE TRIAL OF INHALED NITRIC OXIDE IN CLINICAL LUNG TRANSPLANTATION (2001) (103)
- Colonization With Small Conidia Aspergillus Species Is Associated With Bronchiolitis Obliterans Syndrome: A Two‐Center Validation Study (2013) (98)
- Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis. (2007) (96)
- CXCR2/CXCR2 Ligand Biology during Lung Transplant Ischemia-Reperfusion Injury1 (2005) (95)
- Combined Blockade of the Chemokine Receptors CCR1 and CCR5 Attenuates Chronic Rejection (2004) (93)
- Systemic sclerosis and bilateral lung transplantation: a single centre experience (2010) (93)
- Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes. (2010) (92)
- IL-13 Is Pivotal in the Fibro-Obliterative Process of Bronchiolitis Obliterans Syndrome1 (2007) (86)
- Use of two recipient lists for adults requiring heart transplantation. (2003) (85)
- The long‐term outcome of treated sensitized patients who undergo heart transplantation (2011) (84)
- Early and late results of mitral valve repair in children. (1994) (83)
- Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality. (2011) (76)
- Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation. (2013) (74)
- Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis. (2008) (72)
- Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy. (1995) (71)
- The role of MIG/CXCL9 in cardiac allograft vasculopathy. (2002) (71)
- Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial. (2019) (70)
- Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy. (2000) (68)
- 19: Serum Lactate Is a Highly Sensitive and Specific Predictor of Post Cardiac Transplant Outcomes Using the Organ Care System (2009) (64)
- Altered Levels of CC Chemokines During Pulmonary CMV Predict BOS and Mortality Post‐Lung Transplantation (2008) (64)
- Combined CXCR3/CCR5 Blockade Attenuates Acute and Chronic Rejection1 (2008) (63)
- RANTES PRODUCTION DURING DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (2001) (62)
- Direct gene transfer into donor hearts at the time of harvest. (1995) (61)
- Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience. (2016) (56)
- Mycobacterium abscessus empyema in a lung transplant recipient. (2002) (55)
- CD40 Signaling Replaces CD4+ Lymphocytes and Its Blocking Prevents Chronic Rejection of Heart Transplants (2000) (55)
- Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation (2016) (54)
- Altered Exosomal RNA Profiles in Bronchoalveolar Lavage from Lung Transplants with Acute Rejection. (2015) (54)
- Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection. (2008) (53)
- Cardiac gene transfer by intracoronary infusion of adenovirus vector-mediated reporter gene in the transplanted mouse heart. (1996) (52)
- CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction. (2013) (51)
- Recent Trends in Early Outcome of Adult Patients after Heart Transplantation: A Single‐institution Review of 251 Transplants Using Standard Donor Organs 1 (2002) (50)
- Outcome of hearts with cold ischemic time greater than 300 minutes. A case-matched study. (2005) (50)
- Use of hearts transplanted from donors with atraumatic intracranial bleeds. (2001) (49)
- Lung transplantation in older patients? (2008) (49)
- Increased Bronchoalveolar Lavage Human &bgr;-Defensin Type 2 in Bronchiolitis Obliterans Syndrome after Lung Transplantation (2004) (48)
- Aortic implantation of anomalous left coronary artery. An improved surgical approach. (1995) (47)
- University of Wisconsin solution versus Stanford cardioplegic solution and the development of cardiac allograft vasculopathy. (1995) (47)
- Seventeen-year experience with 1,083 heart transplants at a single institution. (2002) (46)
- Role of CD8+ lymphocytes in chronic rejection of transplanted hearts. (2002) (46)
- CD8+ LYMPHOCYTES AUGMENT CHRONIC REJECTION IN A MHC CLASS II MISMATCHED MODEL (2001) (44)
- CXCR3 Chemokine Ligands During Respiratory Viral Infections Predict Lung Allograft Dysfunction (2012) (43)
- Effect of clopidogrel use post coronary artery bypass surgery on graft patency. (2014) (43)
- Type I immune response cytokine-chemokine cascade is associated with pulmonary arterial hypertension. (2012) (42)
- Modification of the Fontan procedure. Superior vena cava to left pulmonary artery connection and inferior vena cava to right pulmonary artery connection with adjustable atrial septal defect. (1995) (40)
- Orthotopic heart transplantation and concurrent coronary bypass. (1993) (40)
- Results after transplantation using donor hearts with preexisting coronary artery disease. (2003) (40)
- The Role of TGF‐β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome (2016) (38)
- Temporary Mechanical Support with the BVS 5000 Assist Device During Treatment of Acute Myocarditis (1997) (36)
- Donor-recipient sex mismatch portends poor 10-year outcomes in a single-center experience. (2011) (35)
- Proinflammatory High-Density Lipoprotein Results from Oxidized Lipid Mediators in the Pathogenesis of Both Idiopathic and Associated Types of Pulmonary Arterial Hypertension (2015) (35)
- Heart and heart–liver transplantation in adults with failing Fontan physiology (2018) (35)
- Modified reperfusion in clinical lung transplantation: the results of 100 consecutive cases. (2006) (33)
- Long-term outcomes of heart transplantation in older recipients. (2008) (33)
- Lung transplantation and coronary artery disease. (2011) (33)
- Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients (2018) (32)
- Endotype–phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease (2019) (32)
- Chemokines and Transplant Vasculopathy (2008) (32)
- Pulmonary Hypertension Associated with Lung Transplantation Obliterative Bronchiolitis and Vascular Remodeling of the Allograft (2008) (31)
- Usefulness of immune monitoring in lung transplantation using adenosine triphosphate production in activated lymphocytes. (2012) (31)
- Gene Expression Profiling of Bronchoalveolar Lavage Cells Preceding a Clinical Diagnosis of Chronic Lung Allograft Dysfunction (2017) (31)
- Thoracic Organ Transplantation in the United States, 1995–2004 (2006) (30)
- Modified reperfusion and ischemia-reperfusion injury in human lung transplantation. (2003) (30)
- Inflammation/Oxidation in Chronic Rejection: Apolipoprotein A-I Mimetic Peptide Reduces Chronic Rejection of Transplanted Hearts (2007) (29)
- Regulated interleukin-10 expression prevents chronic rejection of transplanted hearts. (2003) (28)
- Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptides (2008) (28)
- Liberalization of Donor Criteria in Lung Transplantation (2003) (26)
- Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis (2018) (26)
- Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation (2017) (25)
- CD8 Lymphocytes are Sufficient for the Development of Chronic Rejection (2004) (25)
- Mitochondrial DNA Stimulates TLR9-Dependent NET Formation in Primary Graft Dysfunction. (2020) (25)
- 294: Prospective Multi-Center Safety and Effectiveness Evaluation of the Organ Care System Device for Cardiac Use (PROCEED) (2008) (25)
- Temporary Venoarterial Extracorporeal Membrane Oxygenation: Ten-Year Experience at a Cardiac Transplant Center (2018) (23)
- Coronary sinus ostial occlusion during retrograde delivery of cardioplegic solution significantly improves cardioplegic distribution and efficacy. (1995) (23)
- Collective review: perioperative uses of inhaled nitric oxide in adults. (2004) (22)
- Expression of major histocompatibility antigens and vascular adhesion molecules on human cardiac allografts preserved in University of Wisconsin solution. (1993) (22)
- Indirect alloreactivity and chronic rejection. (2002) (21)
- Characterization of ventricular assist device-mediated sensitization in the bridge-to-heart-transplantation patient. (2015) (21)
- Ventricular effluent of retrograde cardioplegia in human hearts has traversed capillary beds. (1995) (21)
- The regional capillary distribution of retrograde blood cardioplegia in explanted human hearts. (1995) (21)
- Role of CXCR3 and CCR5 in allograft rejection. (2006) (21)
- Cytoprotective gene HO-1 and chronic rejection in heart transplantation. (2006) (20)
- The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction (2018) (20)
- Results of the OCS Lung EXPAND International Trial Using Portable Normothermic OCS Lung Perfusion System (OCS) to Recruit and Evaluate Extended Criteria Donor (ECD) Lungs (2018) (20)
- The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation (2017) (20)
- Mitochondrial DNA Stimulates TLR9-Dependent Neutrophil Extracellular Trap Formation in Primary Graft Dysfunction (2020) (19)
- Experimental cardiac allograft vasculopathy in mice. (1993) (19)
- Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation (2017) (19)
- Recurrent pulmonary capillary hemangiomatosis after bilateral lung transplantation. (2010) (19)
- HIGH-RESOLUTION CHEST COMPUTED TOMOGRAPHY FINDINGS DO NOT PREDICT THE PRESENCE OF PULMONARY HYPERTENSION IN ADVANCED IDIOPATHIC PULMONARY FIBROSIS (2007) (17)
- Plasma Donor-derived Cell-free DNA Levels Are Increased During Acute Cellular Rejection After Lung Transplant: Pilot Data (2020) (17)
- Staphylococcus via an Interaction With the ELR+ CXC Chemokine ENA‐78 Is Associated With BOS (2015) (17)
- Discovery of non‐HLA antibodies associated with cardiac allograft rejection and development and validation of a non‐HLA antigen multiplex panel: From bench to bedside (2020) (17)
- Diverticulitis occurs early after lung transplantation. (2014) (17)
- Short‐Term Bridge to Heart Transplant Using the BVS 5000 External Ventricular Assist Device 1, 2 (2002) (16)
- Relative roles of heart transplantation and long-term mechanical circulatory support in contemporary management of advanced heart failure - a critical appraisal 10 years after REMATCH. (2011) (16)
- Can improved microvascular perfusion be achieved by using both antegrade and retrograde cardioplegia? (1995) (16)
- The PROCEED II International Heart Transplant Trial with the Organ Care System Technology (OCS) (2013) (16)
- The OCS Lung EXPAND International Trial Interim Results (2016) (16)
- The INSPIRE International Lung Trial with the Organ Care System Technology (OCS (2012) (16)
- Chemokine Receptor Blockade With a Synthetic Nonpeptide Compound Attenuates Cardiac Allograft Vasculopathy (2009) (16)
- Successful Use of Extracorporeal Membrane Oxygenation in an Adult Patient With Toxic Shock-Induced Heart Failure (2015) (15)
- Use of ventricular assist device as a bridge to cardiac transplantation: impact of age and other determinants on outcomes. (2009) (15)
- Gene Expression Profiling of Bronchoalveolar Lavage Cells During Aspergillus Colonization of the Lung Allograft (2016) (15)
- Primary graft dysfunction in heart transplantation (2018) (14)
- Primary graft dysfunction does not lead to increased cardiac allograft vasculopathy in surviving patients. (2013) (14)
- Extended Spectrum &bgr;-Lactamase–Producing Enterobacteriaceae Infection in Heart and Lung Transplant Recipients and in Mechanical Circulatory Support Recipients (2014) (14)
- Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension (2020) (13)
- Lung transplantation and concomitant cardiac surgery: Is it justified? (2016) (12)
- Biologic modification of the immune response in mouse cardiac isografts using gene transfer. (1995) (12)
- Selecting oversized donor cardiac allografts for patients with pulmonary hypertension may be unnecessary. (2014) (12)
- The University of California at Los Angeles heart transplantation experience. (2005) (11)
- Chest Wall Reconstruction for Sternal Dehiscence After Open Heart Surgery (2013) (11)
- Role of CXCR 2 / CXCR 2 ligands in vascular remodeling during bronchiolitis obliterans syndrome (2005) (11)
- Ambulatory central veno-arterial extracorporeal membrane oxygenation in lung transplant candidates. (2019) (11)
- Mid and Long-Term Clinical Results of OCS Lung INSPIRE International Trial (2016) (10)
- Heart transplantation: accelerated graft atherosclerosis. (1995) (10)
- Prospective, multicenter, randomized, controlled trial evaluating the performance of a novel combination powder vs hemostatic matrix in cardiothoracic operations (2019) (10)
- Sixteen-year experience with 1,000 heart transplants at UCLA. (2000) (10)
- Successful use of a pneumatic biventricular assist device as a bridge to transplantation in cardiogenic shock. (2011) (10)
- Evaluation of the safety and efficacy of a new hemostatic powder using a quantitative surface bleeding severity scale (2019) (10)
- Cardiac allograft vasculopathy. (1993) (9)
- Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis (2019) (9)
- The Impact of Allograft CXCL9 during Respiratory Infection on the Risk of Chronic Lung Allograft Dysfunction (2018) (9)
- Multivessel coronary artery bypass surgery without cardiopulmonary bypass. (1999) (9)
- Clinical phenomapping and outcomes after heart transplantation. (2018) (9)
- Tricuspid valve regurgitation after heart transplantation. (2009) (9)
- Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantation. (2009) (9)
- Abstract322 The INSPIRE International Lung Trial with the Organ Care System Technology (OCS (2012) (8)
- Use of a donor heart with symptomatic WPW in an alternate donor program. (2002) (7)
- 1. While millions and millions of lives have been saved, organ transplantation still faces massive problems after 50 years; organ preservation is a big part of the solution (2015) (7)
- 307: The Effectiveness of a Standardized Desensitization Protocol in Reducing Calculated Panel Reactive Antibodies (cPRA) in Sensitized Heart Transplant Candidates: Does It Make Sense To Desensitize? (2010) (7)
- Bronchiolitis obliterans with organizing pneumonia: possible association with human herpes virus-7 infection after lung transplantation. (2001) (7)
- Gene therapy and heart transplantation (2000) (7)
- Temporary mechanical support with the BVS 5000 assist device during treatment of acute myocarditis. (1996) (6)
- Left main coronary artery compression in pulmonary hypertension (2020) (6)
- 462: Does MFI Quantitation of Circulating Antibodies Correlate with Positive Cytotoxicity? (2010) (6)
- The Organ Care System (OCS™) Lung Inspire International Trial Results (2015) (6)
- The In-Hospital Cost of Ventricular Assist Device Therapy: Implications for Patient Selection (2016) (5)
- CD8+ lymphocytes participate in the development of chronic rejection. (2001) (5)
- A Comparison of Distribution Between Simultaneously or Sequentially Delivered Antegrade/Retrograde Blood Cardioplegia (1996) (4)
- Lung transplantation in the Lung Allocation Score era: Medium‐term analysis from a single center (2018) (4)
- Gene Expression Profiling of Bronchoalveolar Lavage Cells Preceding a Clinical Diagnosis of Chronic Lung Allograft Dysfunction. (2017) (4)
- Impact of OCS Lung Portable EVLP on Pulmonary Function and Bronchiolitis Obliterans in Standard Lung Transplant Recipients - Prospective Evidence from the OCS Lung INSPIRE Trial Patients (2016) (4)
- 387: Ex-Vivo Assessment of Donor Hearts with the OCS To Detect Hidden Pathologies (2008) (4)
- Preoperative Cardiac Variables of Diastolic Dysfunction and Clinical Outcomes in Lung Transplant Recipients (2013) (4)
- Management of the anomalous origin of the left coronary artery from the pulmonary artery. (1996) (4)
- Benefits of both physical assessment and electronic health record review to assess frailty prior to heart transplant (2021) (4)
- Current status of normothermic ex-vivo perfusion of cardiac allografts. (2020) (4)
- Multi-frequency forced oscillation technique [FOT] for assessment of lung allograft function: a pilot study (2004) (4)
- Is Lactate Level during Warm Perfusion a Predictor for Post Transplant Outcomes (2013) (4)
- COMBINATION Therapies Including TOCILIZUMAB Decrease the Progression of CLAD: Initial Clinical Experience (2019) (4)
- Heart Transplantation After Ex-Vivo Perfusion of the Donor Hearts: Does it Affect Inotropic Use and Hospital Stay? (2014) (3)
- The INSPIRE Lung International Trial Evaluating the Impact of Portable Ex-vivo Perfusion Using the Organ Care System (OCS™) Lung Technology on Routine Lung Transplant Outcomes (2014) (3)
- Venoarterial Versus Venovenous Extracorporeal Membrane Oxygenation as Bridge to Lung Transplantation (2021) (3)
- Lung Transplantation from Donation after Circulatory Death Donors Following Portable Ex-Vivo Lung Perfusion: Post-Hoc Analysis of OCS Lung EXPAND Trial (2019) (3)
- Successful Tricuspid Valve Replacement in a Patient with Severe Pulmonary Arterial Hypertension and Preserved Right Ventricular Systolic Function (2009) (3)
- Heart transplantation in the early phase of the COVID‐19 pandemic: A single‐center case series (2020) (3)
- Rejection during Pathogenesis of Acute Lung Allograft Role of CXCL 9 / CXCR 3 Chemokine Biology (2003) (3)
- ECMO as a Bridge to Lung Transplantation: An Analysis of the UNOS Database (2016) (3)
- The Impact of Transitioning From In-Person to Virtual Heart Transplantation Selection Committee Meetings: Observational Study (2021) (2)
- The Effect of Monthly Anti-CD25+ Treatment with Basiliximab on the Progression of Chronic Renal Dysfunction after Lung Transplantation (2020) (2)
- Cardiac transplantation at UCLA. (1993) (2)
- The EXPAND Lung International Trial to Evaluate the Safety and Effectiveness of the Portable Organ Care System (OCS™) Lung for Recruiting, Preserving and Assessing Expanded Criteria Donor Lungs for Transplantation (2014) (2)
- Contemporary lung transplantation: the UCLA experience. (2008) (2)
- Ambulatory Status Improves Outcomes in Patients Bridged to Lung Transplantation with ECMO (2018) (2)
- Influence of Pre-Transplant Chronic Kidney Disease (CKD) on Adult Heart Transplant (HT) Outcomes (2013) (2)
- The CCL2/CCR2 Axis in Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome Following Lung Transplantation (2013) (2)
- Outcomes of Heart vs. Heart-Liver Transplantation: UNOS Registry Analysis (2014) (2)
- The INSPIRE International Lung Trial with the Organ Care System Technology (OCS™) - Interim Report (2014) (2)
- 76: Aliskiren: A New Anti-Renin Blood Pressure Medication Appears Safe and Effective in Heart Transplant Recipients (2008) (2)
- Chronic rejection of transplanted hearts (2001) (2)
- 48: The Adverse Effects of Sirolimus in Heart Transplant Patients: Is It Worth It? (2010) (2)
- 12: Successfully Treated Pre-Transplant Sensitized Patients Have Favorable Post-Transplant Outcomes (2008) (2)
- Direct Acting Oral Anticoagulant Utilization, Safety and Efficacy in Heart Transplant (HT) (2018) (2)
- Complement-Fixing Donor-Specific HLA Antibodies Detected By Novel C3d Assay Are Associated With Antibody Mediated Rejection in Heart Transplant Recipients (2015) (2)
- 96: C4d in Heart Transplant Biopsies Does Not Appear to Represent Poor Outcome (2010) (2)
- 720: Oversizing Donor Cardiac Allografts for Patients with Pulmonary Hypertension May Not Be Necessary (2009) (1)
- Do Long Term Outcomes Justify Third Time Redo Lung Transplantation? (2019) (1)
- Use of Cardiac Grafts from Suicidal Hanging Donors: Single-Center Experience. (2020) (1)
- 167: Impact of Age on Outcomes of Ventricular Assist Devices Utilized as Bridge to Cardiac Transplantation (2008) (1)
- Combined Lung-Liver Transplantation: An Analysis of the UNOS Database (2016) (1)
- Is Veno-Arterial ECMO as Safe and Effective as Veno-Venous ECMO for Bridging to Lung Transplantation? (2021) (1)
- Combination, Sequential Therapies Incorporating Tocilizumab Decrease the Progression of Chronic Lung Allograft Dysfunction (CLAD) after Lung Transplantation: Initial Clinical Experience (2019) (1)
- (940) - The Use of Intra-Aortic Balloon Pump Pre-Transplant Is Associated with Worse Outcomes in Heart Transplant Recipients (2017) (1)
- Cardiac Retransplantation: Third Time’s the Charm? (2015) (1)
- Lung Transplantation in Scleroderma (2014) (1)
- (276) – Center for Disease Control High Risk Donor Use in Heart Transplantation: Current Trends (2017) (1)
- Feasibility of Incorporating Frailty Testing into Standard Assessment of Heart Transplant Candidacy. (2020) (1)
- Negative Impact of Ischemia on Short and Long Term Outcomes in Standard Criteria Double Lung Transplants Prospective Evidence from the OCS Lung INSPIRE International Trial Results (2018) (1)
- A Multi-Center Validation Of Pulmonary Aspergillus Fumigatus Colonization As A Risk Factor For Bronchiolitis Obliterans Syndrome After Lung Transplantation (2011) (1)
- Outcomes of Heart Transplantation in Adults with Sarcoidosis: UNOS Registry Analysis (2016) (1)
- Lung Transplantation for Familial Pulmonary Fibrosis (2019) (1)
- Long-Term Results of the OCS Lung Expand International Trial Using Organ Care System Lung Perfusion System (OCS) in Extended-Criteria Donor (ECD) and Donation After Circulatory Death (DCD) Donor Lungs (2022) (1)
- 303: Gender Mismatch in Non-induction/Triple-Drug Regimens: Poor 10-Year Outcomes (2010) (1)
- Outcomes of Heart Transplantation in Adults with Hypertrophic Cardiomyopathy (HCM): UNOS Registry Analysis (2016) (1)
- JAMA Peer Reviewers in 2019. (2020) (1)
- 372: Asymptomatic Positive CMV Serology Is Associated with Increased Risk for the Development of Transplant Coronary Artery Disease (TCAD): Who Needs Symptoms? (2010) (1)
- 304: Success of Immune Monitoring with ImmuKnow (Cylex) To Assess Rejection/Infectious Risk in Heart Transplantation (2008) (1)
- 269: Heart Transplant Rejection with Cardiogenic Shock Supported with Extracorporeal Membrane Oxygenation (ECMO): Outcome from a Single Center Experience (2010) (1)
- (376) - Assessing Risk of Primary Graft Dysfunction in Heart Transplantation (HT) (2017) (1)
- Competing Outcomes of Heart Transplantation in Adults Bridged with Total Artificial Heart (TAH): UNOS Registry Analysis (2016) (1)
- (974) - Influence of Ischemic Time on Post Lung Transplant (LT) Outcomes (2017) (1)
- Daratumumab for Desensitization Therapy in Lung Transplant Candidates (2021) (1)
- 303: Hemodynamic Compromise Rejection: Does the Heart Biopsy Influence Outcome? (2008) (1)
- Augmented concentrations of CX 3 CL 1 are associated with interstitial lung disease in systemic sclerosis (2018) (1)
- The allograft injury marker CXCL9 determines prognosis of anti‐HLA antibodies after lung transplantation (2021) (1)
- Reduced HLA Class II Antibody Response to Proteasome Inhibition (2013) (1)
- Syndrome Process of Bronchiolitis Obliterans IL-13 Is Pivotal in the Fibro-Obliterative (2006) (1)
- Biventricular Bridge to Transplant: Total Artificial Heart (TAH) vs Thoratec Paracorporeal VADs (PVADs) Outcomes Post Heart Transplant (HT) (2016) (1)
- Outcomes of Heart Transplant Recipients Bridged with Percutaneous versus Durable LVADs (2021) (1)
- Defining Clinically Relevant CLAD Phenotypes in Bilateral and Single Lung Transplant Recipients (2014) (1)
- 570: Pre-Transplant FEV1/FVC but Not FEV1 Alone by Pulmonary Function Testing Predicts Poor Outcome after Heart Transplantation: The Bane of COPD (2009) (1)
- Fungal Prophylaxis and Chronic Lung Allograft Dysfunction. (2020) (1)
- JAMA Peer Reviewers in 2020. (2021) (1)
- Modified reperfusion in non-standard donor lungs (2004) (0)
- Genomic Biomarker Surveillance in the Care of Solid Organ Transplant Recipients: An Update for the General Clinician during the Coronavirus (CoVid-19) Pandemic (2020) (0)
- (390) - Trends in Combined Heart-Kidney Transplantation and Impact on Patient Survival (2017) (0)
- Evolving challenges in thoracic transplantation. (2018) (0)
- MIG/CXCL9 neutralization attenuates chronic rejection of transplanted hearts (2003) (0)
- (203) - Treatment with IV Antibiotics Immediately Pre-Transplant Is Associated with Increased Mortality in Heart Transplant Recipients (2017) (0)
- Cardiopulmonary Bypass Use Does Not Affect Outcomes in Single Lung Transplantation (2018) (0)
- CARDIAC RETRANSPLANTATION: HOW FAR HAVE WE COME? (2014) (0)
- MECHANICAL CARDIAC ASSISTANCE USING THE BVS 5000: FIVE-YEAR EXPERIENCE (2000) (0)
- NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes (2022) (0)
- Heart Transplant Outcomes in Patients Listed for Kidney Transplant (2018) (0)
- Socioeconomic Status and Heart Transplantation (2017) (0)
- The INSPIRE International Lung Trial With the Organ Care System Technology (OCSTM) - Interim Report.: Abstract# 2104 (2014) (0)
- 628: Systemic Sclerosis and Lung Transplantation: A Single Center Experience (2009) (0)
- CHEMOKINES MIP-2 AND MCP-1/JE MEDIATE LEUKOCYTE RECRUIT AFTER REPERFUSION (1999) (0)
- Sarcopenia Predicts Outcomes after Lung Transplantation in Older Lung Transplant Candidates (2022) (0)
- Early Survival after Lung Transplantation is Improving in Patients over Age 65 (2018) (0)
- Animal Models for Xenotransplantation (2002) (0)
- Utilization of PHS Increased Risk Donors in Lung Transplant Reduces Median Waitlist Time without Reducing Survival (2019) (0)
- Clinical outcome following concomitant cardiac operation at the time of lung transplantation (2005) (0)
- 125: Chemokine Receptor Blockade Induces Regulatory T Cells (2008) (0)
- Outcomes of Heart Transplantation in Adults With Amyloidosis: UNOS Registry Analysis (2015) (0)
- Long (>6h) versus Short (<6h) Clinical Normothermic Ex-Vivo Portable Lung Preservation: Post-Hoc Analysis of OCS Lung EXPAND Trial (2019) (0)
- 156: Hypercholesterolemia in Heart Transplant Patients on Proliferation-Signal Inhibitors: Is Statin Therapy Effective? (2008) (0)
- Impact of Donor Hepatitis C Viremia on Acute Rejection in Heart Transplant Recipients (2022) (0)
- Elevated Panel Reactive Antibodies in Patients Bridged to Heart Transplantation with Ventricular Assist Devices (2018) (0)
- Improving Utility of MELD-XI Prognostication in Heart Transplant (2018) (0)
- Abstract 216: Causal Role of Oxidized Lipids in Pulmonary Hypertension Development (2017) (0)
- 81: Malignancy Risk in 2007 with Current Immunosuppression Regimens (2008) (0)
- 390: When Is Too Old, Too Old for Redo Heart Transplantation? (2009) (0)
- Impact of National OCS Lung Procurement & Management Program on Post-Transplant Survival - Real World Data from the Thoracic Organ Perfusion (TOP) Post-Approval Registry (2023) (0)
- Should Lungs from Hepatitis C NAT+ Donors Continue to Be Transplanted? A UNOS Registry Analysis (2021) (0)
- 307 Pro-Inflammatory HDL in Idiopathic and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension (PAH) Is Improved Ex Vivo by an Apolipoprotein-AI Mimetic Peptide: A Potential “Target” for Therapies (2011) (0)
- 108: Bronchiolitis Obliterans and Pulmonary Hypertension: A Clinicopathologic Study (2008) (0)
- American Transplant Congress 2009 Program Planning Committees (2009) (0)
- SINGLE INSTITUTION OUTCOME ANALYSIS OF 344 CONSECUTIVE PATIENTS RECEIVING DONOR HEARTS PRESERVED USING UNIVERSITY OF WISCONSIN SOLUTION.: Abstract# 621 (2000) (0)
- Altered collagen subpopulations and the matrix metalloproteinase regulation in the development of atrial fibrillation in atrial dysfunction (2003) (0)
- Mid-Term Outcomes of Heart Transplants from HCV NAT+ Donors (2023) (0)
- Transition From Prostanoid Infusion To Oral Combination Vasodilator Therapy For Severe Pulmonary Arterial Hypertension – A Single Center Experience (2010) (0)
- The Comparison of Survival in Patients with Redo Heart Transplantation by Era (2018) (0)
- Postoperative Atrial Fibrillation in Lung Transplant Recipients with and without Concomitant Modified Maze (2022) (0)
- Benefits of Both Physical Assessments and Electronic Health Record Information to Assess Frailty Prior to Heart Transplant (2021) (0)
- Heart transplantation. (1995) (0)
- Abstract 18029: Dietary Oxydized Lipids Induce Pulmonary Hypertension (2017) (0)
- Assessing Levels of Frailty in a Cohort of Lung Transplant Candidates Using Pre-Transplant Frailty Assessments (2019) (0)
- Impaired Kidney Function and Impact on Survival After Left Ventricular Assist Device Implantation as a Bridge to Transplantation (2018) (0)
- Contemporary Redo Lung Transplantation: An Analysis of the UNOS Database (2015) (0)
- 188: Development of Cytomegalovirus (CMV) Infection during Ongoing Valganciclovir Therapy (2010) (0)
- Extracorporeal Membrane Oxygenation to Transplant Survival: Past, Present and Future (2018) (0)
- Indirect alloreactivity and chronic rejection1 (2002) (0)
- Characteristics and Outcomes of Heart Transplants Following the Change in UNOS Allocation Policy. (2020) (0)
- Prognosis of heart transplant patients in Mashhad University of Medical Sciences (2020) (0)
- 30: CD4+CD25+ Regulatory T-Cells and Cardiac Allograft Vasculopathy (2009) (0)
- 300 Low Absolute Lymphocyte Count at Six Months Post-Heart Transplantation Predictive of Late-Onset CMV (2012) (0)
- 386: Early Permanent Pacemaker after Heart Transplantation Is a Surrogate Marker for Poor Outcome: Possible Immune Mechanisms (2009) (0)
- Non-standard donor lungs: Are they more prone to acute rejection? (2005) (0)
- 76: Obesity Confers Protection from Cardiac Allograft Vasculopathy? (2009) (0)
- Survival for Combined Heart-Lung Transplant (HLT) Recipients over the Past 30 Years (2019) (0)
- Dysphagia Following Tracheostomy in Cardiothoracic Surgery Patients (2014) (0)
- 439: Efficacy of combination therapy with high dosages of IVIG and anti-CD25+ (basiximab) for acute lung allograft rejection or organizing pneumonia: A pilot study (2007) (0)
- Impact of Transitioning from In-Person to Virtual Heart Transplantation Selection Committee Meetings: An Observational Study (Preprint) (2021) (0)
- Normothermic Regional Perfusion in Donation after Circulatory Death Heart Donors May Not Have a Detrimental Effect on Lung Transplant Outcomes (2023) (0)
- (880) - The In-Hospital Cost of Heart Transplantation (2017) (0)
- Use of donor hearts with coronary artery disease (2002) (0)
- Bilateral Orthotopic Lung Transplantation after Resection of Benign Solitary Fibrous Tumor in the Donor Lung (2021) (0)
- Influence of MELD (Model of End-Stage Liver Disease)_XI (eXcluding INR) on Pediatric Post-Heart Transplant (HT) Outcomes (2014) (0)
- Pro-Inflammatory HDL Result from Altered HDL Oxidized Lipid Mediators in Both Idiopathic and Associated Types of Pulmonary Arterial Hypertension (2013) (0)
- 267: ECMO To Salvage Severe Cardiogenic Shock in Advanced Heart Failure and Transplantation (2008) (0)
- RANTES PRODUCTION PARALLELS T CELL RECRUITMENT AND PRECEDES CAV DEVELOPMENT IN MHC I AND MHC II‐INCOMPATIBLE CARDIAC ALLOGRAFTS.: Abstract# 893 Poster Board #‐Session: P150‐III (2000) (0)
- A prospective trial of nitric oxide use in heart transplantation (2001) (0)
- 444: Does High Risk Status Identified by Pre-Transplant Social Worker and Psychiatric Evaluation Predict Outcome after Heart Transplant? (2009) (0)
- CD4+ T LYMPHOCYTES ARE NECESSARY FOR DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (1999) (0)
- Comparison of Survival between Pediatric and Adult Patients after Biventricular Assist Device Implantation: Analysis of the UNOS Database (2014) (0)
- 165: Pre-Transplant Smoking in Heart Transplant Patients: A Marker for Long Term Outcome? (2010) (0)
- Past is Not Prologue - Immune Function Assay Results as a Predictor of Malignancy Post-Heart Transplant (HT) (2019) (0)
- 396: Late Rapidly Progressive Cardiac Allograft Vasculopathy Is Associated with Poor Outcome (2009) (0)
- YKL-40 Production Is Increased in the Lung during Aspergillus Colonization and BOS after Lung Transplantation (2013) (0)
- Outcomes of heart transplant recipients bridged with percutaneous versus durable left ventricular assist devices (2023) (0)
- 163: Everolimus May Have Lower Adverse Effect Profile Compared to Sirolimus in Heart Transplant Patients (2008) (0)
- Incidence and Importance of Donor-Specific HLA Antibody in Heart Transplant Recipients (2014) (0)
- (1283) - Does PGD3 at 0-48 Hours After Lung Transplantation Matter? (2017) (0)
- (57) – Trends in 1A Listing Exceptions in Heart Transplant (HT) Recipients Bridged by Left Ventricular Assist Device (LVAD) Type (2017) (0)
- CHEMOKINE EXPRESSION AND CELLULAR INFILTRATE IN CARDIAC ALLOGRAFT VASCULOPATHY (1999) (0)
- 576: Does Treatment of Sensitized VAD Patients Improved Post Heart Transplant Outcomes? (2009) (0)
- 420: Low Peak Oxygen Consumption by Cardiopulmonary Stress Testing after Heart Transplantation Predicts Poor Outcome (2009) (0)
- 705 Pre-Operative Cardiac Variables and Clinical Outcomes in Patients with Bilateral Lung Transplants (2012) (0)
- 357: Augmentation of Type 1 immune response cytokines/chemokines is associated with pulmonary arterial hypertension (2007) (0)
- Transplant Ischemia-Reperfusion Injury CXCR 2 / CXCR 2 Ligand Biology during Lung (2005) (0)
- 374: The Threat of Medication Miscommunication in Non-English Speaking Heart Transplant Recipients (2010) (0)
- Renal Failure after Lung Transplantation: A Bump in the Road or a Grave Complication? (2023) (0)
- 211: Survival of Lung Transplant Recipients with Concomitant Myocardial Revascularization (2009) (0)
- Good News for Patients with Dendriform Pulmonary Ossification. (2022) (0)
- Sustained rantes production is necessary for CAV development. (2001) (0)
- 87: Combined CXCR3 and CCR5 blockade attenuates acute and chronic rejection (2006) (0)
- Combined chemokine receptor blockade: a novel strategy to control acute and chronic rejection (2005) (0)
- 144 Does Age Matter in Lung Transplantation (2012) (0)
- Lung Transplantation from HCV NAT+ Donors: Reassuring Mid-Term Outcomes (2023) (0)
- 370: The Incidence and Outcome of Sensitization in Patients Awaiting Re-do Heart Transplantation (2010) (0)
- Outcomes in Patients with Ischemic Cardiomyopathy (ICM) Post-Heart Transplant (HT) by Era (2013) (0)
- 57-P: Virtual Crossmatch Significantly Increases Access for Sensitized Patients to Heart Transplantation (2010) (0)
- 148: Are Circulating Antibodies Necessary To Make a Diagnosis of Antibody-Mediated Rejection? (2010) (0)
- Predictors of Grade 3 Primary Graft Dysfunction in Lung Transplant Recipients (2022) (0)
- 658: The Impact of Aspergillus Colonization on Acute Rejection and Lymphocytic Bronchiolitis in Lung Transplant Patients (2009) (0)
- OUTCOME OF MECHANICAL ASSISTANCE AFTER PRIMARY GRAFT FAILURE FOLLOWING ORTHOTOPIC HEART TRANSPLANTATION (2002) (0)
- Abstract 3054: Comparison of Transforming Growth Factor-{beta}1 Expression in Aortic Wall of Thoracic Aortic Aneurysm Versus Dissection (2007) (0)
- The Mystery of Inappropriate Hypoxia After Single Lung Transplant (2022) (0)
- COMPARISON OF QID AND BID REGIMEN FOR INITIATION OF CYCLOSPORINE TREATMENT FOLLOWING HEART TRANSPLANTATION.: Abstract# 481 Poster Board #‐Session: P121‐II (2000) (0)
- Ex-Vivo Lung Perfusion May Have a Detrimental Impact on Lung Transplants from Donation after Circulatory Death Donors (2023) (0)
- (204) - More Inactive Time on Heart Transplant List Results in Increased Post Transplant Mortality (2017) (0)
- 244: The Outcome of Treatment of 100% PRAs in Heart Failure Patients Awaiting Heart Transplantation (2009) (0)
- (163) – Cluster Analysis and Dynamic Phenomapping to Guide Clinical Management After Heart Transplantation (2017) (0)
- 2. Challenge of organ shortage is enormous, but we’re heading towards a future where we have time and ability to improve and augment organs before more and better transplants (2015) (0)
- Abstract 2675: Up-Regulated Transforming Growth Factor-{beta}1 Co-Localized with Elastin Lamella in Aortic Wall Contributes to Thoracic Aortic Dissection (2007) (0)
- Pre-Transplant Frailty Assessment is Not Associated with Incidence of Pneumonia after Lung Transplantation (2021) (0)
- 525 The Fibroproliferative Chemokine, Eotaxin/CCL11, Is Upregulated in Lung Transplant Recipients Colonized with Aspergillus – A Link to BOS? (2012) (0)
- 83: Transition of Pediatric Heart Transplant Patients to the Adult Heart Transplant Program: Are They Doomed To Be Rejected? (2010) (0)
- Timing of Lung Transplantation for Seemingly Irreversible COVID-19 Lung Disease: A Cautionary Tale (2022) (0)
- Recipient Working Status is Independently Associated with Outcomes in Heart Transplantation (2018) (0)
- 288: Improved Clinical Outcomes Using Bi-Ventricular Assist Devices as Bridges to Transplant in Critically Ill Patients (2008) (0)
- Ascending Aortic Pseudoaneurysm: A Rare Complication of Transcatheter Aortic Valve Replacement and Thoracic Surgery. (2022) (0)
- Regarding Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft Vasculopathy Problems With Listing Patients Receiving Clopidogrel for Re-Transplantation Reply (2009) (0)
- Chapter 70 – Liver and Heart Transplantation (2013) (0)
- 133: Focus on inflammation and oxidation: A new approach to management of cardiac allograft vasculopathy (2006) (0)
- 421: Should Patients with Coronary Artery Disease Undergo Lung Transplantation? (2010) (0)
- Comparison of Chart-Based and Physical Frailty Assessment in Heart Transplant Candidates to Predict Clinical Outcomes (2023) (0)
- 199: Survival Benefit of Contemporary Lung Transplantation in Patients with IPF (2009) (0)
- Optimizing Immunosuppression: Steroid Weaning Strategies in Heart Transplant (HT) (2018) (0)
- 246: Outcome of Retrospective Positive Donor Specific Crossmatch after Heart Transplantation: Are They Doomed? (2009) (0)
- 373: Does Race Mismatch Have an Impact on Outcome after Heart Transplantation? (2010) (0)
- Abstract 2890: The Long Term Outcome Of Treated Presensitized Patients Who Undergo Heart Transplantation: Is It Successful? (2007) (0)
- 266: Right Ventricular Dysfunction Immediately Post Transplant – A Marker for Poor Outcome? (2009) (0)
- Outcomes of ECMO Bridge to Lung Transplantation are Dependent on Age (2018) (0)
- Single vs. Double Lung Transplantation in Patients over Age 65 (2018) (0)
- Ex-Vivo Perfusion of Human Donor Hearts Reduces Cold Ischemia Time (2013) (0)
- Primary Graft Dysfunction in Lung Transplantation: A Detailed Predictive Model (2016) (0)
- 101: Are Recipients from Heart Donors Listed as Homeless at Increased Risk for Poor Outcome after Heart Transplantation? (2010) (0)
- Influence of the MELD-XI (Model of End-Stage Liver Disease Excluding INR) on Heart Transplant Outcomes (2016) (0)
- 82: Long-Term Risks Post Steroid Weaning: Not so Rosy after All (2008) (0)
- 322: Spare Me the Renal Sparing Protocol – Poor Long Term Outcomes (2009) (0)
- 472: The Problem of Rejection in Redo Heart Transplant Recipients (2009) (0)
- Comparing Bortezomib to Traditional Therapies for Antibody-Mediated Rejection (AMR): Out with the Old? (2013) (0)
- (62) - Trends in 1A Listing Exceptions in Heart Transplant (HT) Recipients Bridged with Mechanical Circulatory Support (MCS) (2017) (0)
- Serum Hepcidin Antimicrobial Peptide Levels Predict Infection After Lung Transplantation (2014) (0)
- Survival in Re-Do Heart Transplant: Does Dual Organ Allocation Make a Difference? (2018) (0)
- Outcomes of Alcohol Cardiomyopathy Post Heart Transplantation (2015) (0)
- Association for Academic Surgery Diverticulitis occurs early after lung transplantation (2014) (0)
- ISCHEMIA TIME PROLONGATION DOES NOT PROMOTE CHEMOKINE EXPRESSION OR LEUKOCYTE RECRUITMENT AFTER HEART TRANSPLANTATION (1999) (0)
- A Febrile, Hypotensive Patient With Bilateral Lung Crackles. (2019) (0)
- 272: Persistent Pulmonary Hypertension in Heart Transplant Patients: Is This a Recipe for Long-Term Failure? (2010) (0)
- Abstract 2583: Successful Use Of Immune Monitoring (Cylex) In Heart Trasnplantation For Rejection And Infection Risk (2007) (0)
- 176: Accommodation after Heart Transplantation: Does It Exist? (2010) (0)
- Ex-Vivo Heart Perfusion Using the Organ Care System Reduces the Donor Heart Cold Ischemia Time (2015) (0)
- Influence of HLA Mismatch on Outcomes After Heart Transplantation: UNOS Registry Data (2015) (0)
- 504: The Efficacy of Shorter Duration CMV Prophylaxis after Heart Transplantation (2009) (0)
- Outcomes of Heart Transplantation in Adults With Congenital Heart Disease: UNOS Registry Analysis (2015) (0)
- Characteristics and Outcomes of Lung Transplants Performed with Ex-Vivo Lung Perfusion (2022) (0)
- Left Ventricular Assist Devices for Acute and Chronic Heart Failure (2009) (0)
- 145: Does a Normal Angiogram Further from Heart Transplantation Confer Less Chance To Develop CAV? Should We Still Do Annual Angiograms Late after Transplantation? (2010) (0)
- It's a Long Road to Transplant: A Case of Prolonged ECLS Use as a Bridge to HLT (2022) (0)
- 211: The Importance of Anti-HLA DQ Antibodies as a Risk Factor for the Development of Transplant Coronary Artery Disease (TCAD) after Heart Transplantation (2010) (0)
- Is There a Mortality “Weekend Effect” in Cardiac Transplantation? (2019) (0)
- Utility of First Year Surveillance Lung Allograft HRCT Scan for Predicting of Early CLAD (2023) (0)
- 332: Upregulated Transforming Growth Factor-β1 Expression and Distribution in Coronary Arterial Wall from Patients with Cardiac Allograft Vasculopathy Versus Ischemic Cardiomypathy (2008) (0)
- Temporary Extracorporeal Membrane: Oxygenation: Ten-Year Experience at a Cardiac Transplant Center (2015) (0)
- Redo Heart Transplantation: The Comparison of Survival Based on the Time Interval Between Transplants (2018) (0)
- First Report of the Organ Care System (OCS) Thoracic Organ Perfusion (TOP) Post-Approval Registry (2023) (0)
- IL‐10 TRANSGENE PREVENTS CARDIAC ALLOGRAFT VASCULOPATHY.: Abstract# 724 (2000) (0)
- 371: First-Year Statin Resistant Hypercholesterolemia: A Cause for Concern in the Development of Cardiac Allograft Vasculopathy (2008) (0)
- Use of Donor HCV NAT Positive Hearts: Expanding the Donor Pool? (2019) (0)
- Impact of OCS Lung Warm Perfusion Times on Post-Transplant Survival - "Real-World" Experience from Thoracic Organ Perfusion (TOP) Registry (2023) (0)
- Postoperative Renal Failure in Patients Undergoing Isolated Heart Transplantation: What are the Outcomes? (2023) (0)
- Increased BAL human β-defensin-2 bronchiolitis obliterans syndrome after lung transplantation (2002) (0)
- Lung Transplantation in the LAS Era: Long-Term Analysis (2016) (0)
- Influence of Chronic Kidney Disease (CKD) in Outcomes Post Heart Transplant (HT) in Pediatric Recipients (2015) (0)
- 80: End-Stage Renal Disease after Heart Transplantation: The Benefits of Kidney Transplantation (2008) (0)
- MANAGEMENT OF A LARGE ASCENDING AORTIC PSEUDOANEURYSM: A RARE COMPLICATION OF THORACIC SURGERY AND TRANSCATHETER AORTIC VALVE REPLACEMENT (2022) (0)
- CSF‐1 DEFICIENCY ACCELERATES CARDIAC ALLOGRAFT REJECTION.: Abstract# 908 Poster Board #‐Session: P165‐III (2000) (0)
- The FEV1/FVC Ratio Adds To The Prognostic Value Of Bronchiolitis Obliterans Syndrome Stage 0-p In Lung Transplant Recipients (2011) (0)
- 435: CXCR3 and CCR5 in Acute and Chronic Rejection (2009) (0)
- Comprar Khonsari's Cardiac Surgery: Safeguards and Pitfalls in Operative Technique, 5ª Ed. | Abbas Ardehali | 9781451183689 | Lippincott Williams & Wilkins (2016) (0)
- 205: Long Term Outcome of Heart Transplant in the Elderly (2008) (0)
- 511: The Benefit of Immune Monitoring (Cylex): A Review of 864 Immune Monitoring Assays in Heart Transplantation (2009) (0)
- The synthetic peptide D4F attenuates cardiac allograft vasculopathy (2005) (0)
- Lung Transplantation in Septuagenarians (2016) (0)
- FRI0257 Augmented Concentrations of Cx3cl1 Are Associated with Progressiv Interstitial Lung Disease in Systemic Sclerosis (2016) (0)
- Abstract P122: Characterization of Ventricular Assist Device Mediated Sensitization in the Bridge to Heart Transplant Patient (2011) (0)
- 248: Tricuspid Valve Regurgitation (TR) after Heart Transplantation Using the Bicaval Anastomosis Technique (2008) (0)
- Abstract 19163: A Novel Key Role of LDL and its Receptor in Pre-clinical and Clinical Pulmonary Hypertension (2017) (0)
- SHORT‐TERM BRIDGE TO TRANSPLANT USING THE BVS 5000 VENTRICULAR ASSIST DEVICE.: Abstract# 469 Poster Board #‐Session: P109‐II (2000) (0)
- Outcomes of Adult Heart (HT) Versus Heart-Kidney (H+K) Transplant: Influence of CKD (Chronic Kidney Disease) Stage (2013) (0)
- Bronchiolitis Obliterans Syndrome in Lung Transplantation: A Predictive Model (2018) (0)
- 457: Does Listing Status Affect Cost of Heart Transplantation? (2010) (0)
- 684: Intraoperative Versus Postoperative Rabbit Anti-Thymoglobulin Globulin Induction for Bilateral Lung Transplantation: A Single Center Randomized Double Blind Placebo Controlled Trial (2009) (0)
- Predictors and Outcomes of Post-Operative Extracorporeal Membrane Oxygenation at 72 Hours Following Lung Transplantation (2023) (0)
- SIMULTANEOUS CXCR3 AND CCR5 BLOCKADE PROLONGS ALLOGRAFT SURVIVAL AND REDUCES T-CELL PROLIFERATION (2006) (0)
- (1186) – Heart Transplantation in Prostate Cancer Patients (2017) (0)
- 79: The Innocence of Coronary Spasm after Heart Transplantation (2008) (0)
- 491: The use of ECMO/intra-aortic balloon pump to support hemodynamics in patients with cardiogenic shock due to severe rejection (2007) (0)
- Does Gender Influence Survival of Heart Transplant (HT) Recipients Bridged with LVAD Support (2013) (0)
- Post Heart Transplant (HT) Survival in Pediatric Patients with Left Ventricular and Biventricular Assist Devices (LVAD/BIVAD): UNOS Registry Analysis (2014) (0)
- Central Ambulatory Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation (2019) (0)
- Sustained production of the chemokine MIG precedes intimal thickening in chronic rejection. (2001) (0)
- Do We Really Need to Do Lung Transplants at Night? (2021) (0)
- Negative Impact of Primary Graft Dysfunction Grade 3 within the Initial 72 Hours on Short and Long Term Clinical Outcomes in Standard Criteria Double Lung Transplants: Prospective Evidence from the OCS Lung INSPIRE International Trial Results (2018) (0)
- 463: Addressing the Myth of Elevated Bilirubin as a Contraindication to Heart Transplantation (2009) (0)
- 84: Chemokine receptor blockade with a synthetic non-peptide compound attenuates cardiac allograft vasculopathy (2006) (0)
- Lung transplantation for connective tissue disorders (2016) (0)
- Increased prevalence of antiphospholipid antibodies in primary and secondary pulmonary and arterial hypertension (2002) (0)
- Is Combined Lung-Liver Transplantation Justified? 30-Year Review of UNOS Database (2019) (0)
- 371: First Angioplasty Does Not Appear To Alter Outcome in Heart Transplant Patients with Newly Diagnosed Transplant Coronary Artery Disease (2010) (0)
- 221: Comparison of Survival and Costs between Transplantation and Medical Treatment of End Stage Heart Failure (2008) (0)
- The impact of pre-transplant donor specific anti-HLA antibodies (DSAs) on lung transplant outcome: A single center experience (2019) (0)
- Contemporary Lung Transplantation (2008) (0)
- Reduced Readmissions with Enoxaparin Bridging for Subtherapeutic INR in MCS (2018) (0)
- Outcomes of Heart Transplant (HT) Recipients Bridged with BIVAD (BiVentricular Assist Device) (2014) (0)
- 88: The Impact of Aspergillus Infection on Survival and Bronchiolitis Obliterans Syndrome in Lung Transplantation (2008) (0)
- 329: Early “surveillance” biopsies detect lung allograft rejection and lymphocytic bronchiolitis (2007) (0)
- 563: Lack of Sensitization in Patients Awaiting Heart Transplantation on Heartmate II Axial Flow Assist Devices (2010) (0)
- 422: CXCR3 and CCR5 blockade prevents acute rejection via induction of regulatory CD4 lymphocytes (2007) (0)
- Combined AlloSure and AlloMap Testing in Multi-Organ Heart Transplantation Rejection Surveillance. (2020) (0)
- Survival Post Heart Transplant by Listing Strategy (2018) (0)
- Pulmonary arterial hypertension [PAH] is associated with increased capillary blood proangiogenic C-X-C chemokines (2002) (0)
- Sarcopenia is Distinct from Physical Frailty and Significantly Associated with Length of Stay after Transplantation (2021) (0)
- Graft Chemokines and Transplant Vasculopathy (2008) (0)
- Extra-corporeal Membrane Oxygenation (ECMO) as a Bridge to Lung Transplantation: Outcomes in the Current Era (2018) (0)
- LVAD Patients with CKD: Are Two Organs Better than One? (2018) (0)
- TRANSITION FROM PROSTANOID TO COMBINATION ORAL THERAPY FOR PULMONARY ARTERIAL HYPERTENSION (2011) (0)
- Chemokine MIG/CXCl9 stimulates CD4 T lymphocyte proliferation and IFN-γ expression (2004) (0)
- 639: Surreptitious Aspergillus Colonization Is Not Associated with Poor Outcome While on Suppressive Azole Therapy (2009) (0)
- Outcomes in Patients Older than 65 Years of Age Post Heart (HT) & Heart-Kidney Transplant (HKT) (2016) (0)
- 210: Review of 12,703 Endomyocardial Biopsies: The Truth of Quilty Lesions in the Cyclosporine and Tacrolimus Era (2010) (0)
- 359: Highly Sensitized Patients on VAD Support Awaiting Heart Transplant on a Ventricular Assist Device (VAD) Appear To Have a Less Robust Immune Response Compared to Non-VAD Patients (2010) (0)
- Steps towards Personalization of Clinical Care in Era of Precision Medicine. Time Dependent Immune Phenomapping in Heart Transplantation and Emergence of Anti-HLA Class I and II Antibodies (2016) (0)
- Intellectual Disability and Pediatric Lung Transplantation (2018) (0)
This paper list is powered by the following services:
Other Resources About Abbas Ardehali
What Schools Are Affiliated With Abbas Ardehali?
Abbas Ardehali is affiliated with the following schools:
